期刊文献+

Th1/Th2细胞因子在不同临床特征的EMs患者差异性表达 被引量:3

Different Expressions of Th1 and Th2 Cell Factors in Endometriosis(EMs) with Different Clinical Features
原文传递
导出
摘要 目的:研究Th1、Th2各细胞因子在不同临床特征的子宫内膜异位症(EMs)患者差异性表达。方法:收集120例拟诊为"EMs"的患者临床资料。患者均于卵泡期行腹腔镜手术探查,术后经病理证实EMs者87例,非EMs者33例,将EMs组和非EMs组患者分别以主要主诉及临床特征如不孕、痛经/慢性盆腔痛、月经异常、卵巢受累进行再分组,应用ELISA法检测患者腹腔液中IL-2、IL-4、IL-6、IL-10、TNF-α、IFN-γ的表达。结果:以"痛经/盆腔痛"为主要临床特征的EMs组与非EMs组患者腹腔液TNF-α表达有显著差异,显示其与EMs盆腔痛有相关性(P=0.00);以"不孕"为主要临床特征的EMs组与非EMs组患者腹腔液IL-2表达有统计学差异(P=0.03);在检查有盆腔包块或月经异常的患者,术中探查卵巢子宫内膜异位囊肿或明确卵巢受累者的腹腔液IL-10在EMs组与非EMs组表达有统计学差异(P=0.01)。结论:在EMs患者Th1/Th2漂移的免疫异常中,不同的细胞因子在发病和临床特征的形成中发挥作用。 Objective: To study different expressions of Th1 and Th2 cell factors in endometriosis(EMs) patients with different clinical features.Methods: A total of 120 patients who were hospitalized and intended to be diagnosed as EMs in clinic,were examined by laparoscopic surgery during follicular phrase.After operation,87 cases were confirmed as EMs by pathology and 33 cases were non-EMs.Two groups of patients were regrouped according to clinical features: infertility,dysmenorrhea/chronic pelvic pain,menoxenia/ovarian involvement.ELISA method was used to measure different expressions of IL-2,IL-4,IL-6,IL-10,TNF-a,IFN-g in peritoneal fluid.Results: There was a significant difference in the expression of TNF-a in peritoneal fluid between EMs and non-EMs groups with dysmenorrhea/chronic pelvic pain(P=0.00).There was a significant difference in the expression of IL-2 in peritoneal fluid between EMs and non-EMs groups with infertility(P=0.03).In patients with pelvic mass and menoxenia,there was a significant difference in expression of IL-10 in peritoneal fluid between group with intraoperative exploration of endometrial cyst and group with confirmation of ovarian involvement(P=0.01).Conclusion: In the dysimmunity of Th1 and Th2 drifting,different cytokines play different key roles in pathogenesis and formation of clinical features.
出处 《生殖与避孕》 CAS CSCD 2012年第3期175-178,174,共5页 Reproduction and Contraception
基金 宁夏自然科学基金项目(NZ10123) 宁夏银川市科技局攻关项目 宁夏医科大学附属医院面上项目
关键词 子宫内膜异位症(EMs) 临床特征 细胞因子 TH1 TH2 endometriosis(EMs) clinical features cytokines Th1 Th2
  • 相关文献

参考文献5

二级参考文献49

  • 1辛志敏,徐滨,孙莹璞,谢青贞,曹路敏,苏迎春,郭艺红.PGE_2促进培养的人子宫内膜细胞VEGF的表达[J].基础医学与临床,2005,25(10):938-943. 被引量:4
  • 2曲凡,马文光,杨东霞,马宝璋.异位宁对子宫内膜异位症大鼠血清白介素2及白介素10作用的实验研究[J].时珍国医国药,2006,17(11):2153-2154. 被引量:3
  • 3彭丽秀,张怡,周昌菊.TNFR1在子宫内膜异位症和子宫腺肌病表达的研究[J].生殖与避孕,2006,26(11):672-675. 被引量:4
  • 4[1]Mosmann TR,Sad S.The expanding universe of T cell subset-Th1,Th2 and more.Immunol Today,1996,17(3):138
  • 5[2]Wegmann TG,Lin H,Guibert L,et al.Bi-directional cytokine interaction in the maternal-fetal relationship:is successful pregnancy a Th2 phenomenon?Immunol Today,1993,14(7):353
  • 6[3]Raghupathy R.Th1-type immunity is incompatible with successful pregnancy.Immunol Today,1997,18(10):478
  • 7[4]Saito S,Sakai M,Sasaki Y,et al.Quantitative analysis of peripheral blood Th0,Th1,Th2 and the Th1/Th2 cell ratio during normal human pregnancy and preeclampsia.Clin Exp Immunol,1999,117(3):550
  • 8[5]Chow YH,Chiang BL,Lee YL,et al.Development of Th1 and Th2 populations and the nature of immune response to hepatitis B DNA vaccines can be modulated by co-delivery of various cytokine genes.J Immunol,1998,160(3):1320
  • 9Hsu CC, Yang BC, Wu MH et al. Enhanced interleukin-4 expression in patients with endometriosis [J3 . Fertil Steril, 1997, 67:1059.
  • 10Enriquez J, Klinger J, Arturo JA et al. Peritonitis in continuous ambulatory peritoneal dialysis: cytokines in peritoneal fluid and blood [ J]. Adv Perit Dial, 2002, 18:177.

共引文献19

同被引文献80

  • 1刘润侠,刘艳巧.补肾活血方对子宫内膜异位症不孕患者子宫内膜的影响[J].中国中医药信息杂志,2005,12(6):14-15. 被引量:12
  • 2潘建青,曾叶,杨业金,程静,欧阳曙明.雷公藤内酯醇抑制小鼠巨噬细胞血管内皮生长因子的表达[J].生殖与避孕,2006,26(3):142-145. 被引量:3
  • 3McLeod BS, Retzloff MG. Epidemiology of endometriosis: an assessment of risk factors. Clin Obstet Gynecol, 2010, 53 (2):389-96.
  • 4Tulandi T, Redwine D. Endometriosis: advances and controversies. New York: CRC Press, 2003.
  • 5Gazvani R, Coyne L, Anttila T, et al. Antibodies to Chlamydia trachomatis in serum and peritoneal fluid of women with endometriosis. Hum Fertil (Camb), 2011, 14(1):64-7.
  • 6Ulukus M, Arici A. Immunology of endometriosis. Minerva Ginecol, 2005, 57(3):237-48.
  • 7Bruner-Tran KL, Herington JL, Duleba AJ, et al. Medical management of endometfiosis: emerging evidence linking in- flammation to disease pathophysiology. Minerva Ginecol, 2013, 65(2):199-213.
  • 8Lohani K, Shetty S, Sharma P, et al. Pseudomyxoma peritonei: inflammatory responses in the peritoneal microenvironment. Ann Surg Oncol, 2013, 21(5):1441-7.
  • 9Laschke MW, Rudzitis-Auth J, Menger MD. Regional treatment with liquid barrier agents: a novel therapeutic option for intraperitoneal endometriosis? Med Hypotheses, 2013, 80(6):709-10.
  • 10Herington JL, Bruner-Tran KL, Lucas JA, et al. Immune interactions in endomeWiosis. Expert Rev Clin Immunol, 2011, 7(5):611-26.

引证文献3

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部